Global Veterinary Biologics Market Research Report 2021

Global Veterinary Biologics Market Research Report 2021

Table of Contents
1 Veterinary Biologics Market Overview
1.1 Product Overview and Scope of Veterinary Biologics
1.2 Veterinary Biologics Segment by Type
1.2.1 Global Veterinary Biologics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Vaccines
1.2.3 Monoclonal Antibodies
1.3 Veterinary Biologics Segment by Application
1.3.1 Veterinary Biologics Sales Comparison by Application: (2021-2027)
1.3.2 Llivestock
1.3.3 Equine
1.3.4 Other
1.4 Global Veterinary Biologics Market Size Estimates and Forecasts
1.4.1 Global Veterinary Biologics Revenue 2016-2027
1.4.2 Global Veterinary Biologics Sales 2016-2027
1.4.3 Veterinary Biologics Market Size by Region: 2016 Versus 2021 Versus 2027
2 Veterinary Biologics Market Competition by Manufacturers
2.1 Global Veterinary Biologics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Veterinary Biologics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Veterinary Biologics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Veterinary Biologics Manufacturing Sites, Area Served, Product Type
2.5 Veterinary Biologics Market Competitive Situation and Trends
2.5.1 Veterinary Biologics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Veterinary Biologics Players Market Share by Revenue
2.5.3 Global Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Biologics Retrospective Market Scenario by Region
3.1 Global Veterinary Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Veterinary Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Veterinary Biologics Market Facts & Figures by Country
3.3.1 North America Veterinary Biologics Sales by Country
3.3.2 North America Veterinary Biologics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Veterinary Biologics Market Facts & Figures by Country
3.4.1 Europe Veterinary Biologics Sales by Country
3.4.2 Europe Veterinary Biologics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Veterinary Biologics Market Facts & Figures by Region
3.5.1 Asia Pacific Veterinary Biologics Sales by Region
3.5.2 Asia Pacific Veterinary Biologics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Veterinary Biologics Market Facts & Figures by Country
3.6.1 Latin America Veterinary Biologics Sales by Country
3.6.2 Latin America Veterinary Biologics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Veterinary Biologics Market Facts & Figures by Country
3.7.1 Middle East and Africa Veterinary Biologics Sales by Country
3.7.2 Middle East and Africa Veterinary Biologics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Veterinary Biologics Historic Market Analysis by Type
4.1 Global Veterinary Biologics Sales Market Share by Type (2016-2021)
4.2 Global Veterinary Biologics Revenue Market Share by Type (2016-2021)
4.3 Global Veterinary Biologics Price by Type (2016-2021)
5 Global Veterinary Biologics Historic Market Analysis by Application
5.1 Global Veterinary Biologics Sales Market Share by Application (2016-2021)
5.2 Global Veterinary Biologics Revenue Market Share by Application (2016-2021)
5.3 Global Veterinary Biologics Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Zoetis Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Boehringer Ingelheim Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ceva Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Corporation Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 CAHIC Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Corporation Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 HVRI Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Ringpu Biology
6.6.1 Ringpu Biology Corporation Information
6.6.2 Ringpu Biology Description and Business Overview
6.6.3 Ringpu Biology Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ringpu Biology Product Portfolio
6.7.5 Ringpu Biology Recent Developments/Updates
6.8 Yebio
6.8.1 Yebio Corporation Information
6.8.2 Yebio Description and Business Overview
6.8.3 Yebio Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Yebio Product Portfolio
6.8.5 Yebio Recent Developments/Updates
6.9 DHN
6.9.1 DHN Corporation Information
6.9.2 DHN Description and Business Overview
6.9.3 DHN Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 DHN Product Portfolio
6.9.5 DHN Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Corporation Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 WINSUN Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Elanco/Eli Lilly
6.11.1 Elanco/Eli Lilly Corporation Information
6.11.2 Elanco/Eli Lilly Veterinary Biologics Description and Business Overview
6.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Elanco/Eli Lilly Product Portfolio
6.11.5 Elanco/Eli Lilly Recent Developments/Updates
6.12 Virbac
6.12.1 Virbac Corporation Information
6.12.2 Virbac Veterinary Biologics Description and Business Overview
6.12.3 Virbac Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Virbac Product Portfolio
6.12.5 Virbac Recent Developments/Updates
6.13 Jinyu Bio-Technology
6.13.1 Jinyu Bio-Technology Corporation Information
6.13.2 Jinyu Bio-Technology Veterinary Biologics Description and Business Overview
6.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Jinyu Bio-Technology Product Portfolio
6.13.5 Jinyu Bio-Technology Recent Developments/Updates
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Corporation Information
6.14.2 ChengDu Tecbond Veterinary Biologics Description and Business Overview
6.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.14.4 ChengDu Tecbond Product Portfolio
6.14.5 ChengDu Tecbond Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Corporation Information
6.15.2 CAVAC Veterinary Biologics Description and Business Overview
6.15.3 CAVAC Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.15.4 CAVAC Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Kyoto Biken
6.16.1 Kyoto Biken Corporation Information
6.16.2 Kyoto Biken Veterinary Biologics Description and Business Overview
6.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Kyoto Biken Product Portfolio
6.16.5 Kyoto Biken Recent Developments/Updates
6.17 FATRO
6.17.1 FATRO Corporation Information
6.17.2 FATRO Veterinary Biologics Description and Business Overview
6.17.3 FATRO Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.17.4 FATRO Product Portfolio
6.17.5 FATRO Recent Developments/Updates
6.18 Vaksindo
6.18.1 Vaksindo Corporation Information
6.18.2 Vaksindo Veterinary Biologics Description and Business Overview
6.18.3 Vaksindo Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Vaksindo Product Portfolio
6.18.5 Vaksindo Recent Developments/Updates
6.19 Bio-Labs
6.19.1 Bio-Labs Corporation Information
6.19.2 Bio-Labs Veterinary Biologics Description and Business Overview
6.19.3 Bio-Labs Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Bio-Labs Product Portfolio
6.19.5 Bio-Labs Recent Developments/Updates
6.20 Avimex Animal
6.20.1 Avimex Animal Corporation Information
6.20.2 Avimex Animal Veterinary Biologics Description and Business Overview
6.20.3 Avimex Animal Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Avimex Animal Product Portfolio
6.20.5 Avimex Animal Recent Developments/Updates
7 Veterinary Biologics Manufacturing Cost Analysis
7.1 Veterinary Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Veterinary Biologics
7.4 Veterinary Biologics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Veterinary Biologics Distributors List
8.3 Veterinary Biologics Customers
9 Veterinary Biologics Market Dynamics
9.1 Veterinary Biologics Industry Trends
9.2 Veterinary Biologics Growth Drivers
9.3 Veterinary Biologics Market Challenges
9.4 Veterinary Biologics Market Restraints
10 Global Market Forecast
10.1 Veterinary Biologics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Veterinary Biologics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Veterinary Biologics by Type (2022-2027)
10.2 Veterinary Biologics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Veterinary Biologics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Veterinary Biologics by Application (2022-2027)
10.3 Veterinary Biologics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Veterinary Biologics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Veterinary Biologics by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Veterinary Biologics Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Veterinary Biologics Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Veterinary Biologics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Veterinary Biologics Covered in This Study
Table 5. Global Veterinary Biologics Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Veterinary Biologics Sales Share by Manufacturers (2016-2021)
Table 7. Global Veterinary Biologics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Veterinary Biologics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Veterinary Biologics Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Veterinary Biologics Manufacturing Sites and Area Served
Table 11. Manufacturers Veterinary Biologics Product Type
Table 12. Global Veterinary Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Veterinary Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Biologics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Veterinary Biologics Sales by Region (2016-2021) & (K Units)
Table 16. Global Veterinary Biologics Sales Market Share by Region (2016-2021)
Table 17. Global Veterinary Biologics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Veterinary Biologics Sales by Country (2016-2021) & (K Units)
Table 19. North America Veterinary Biologics Sales Market Share by Country (2016-2021)
Table 20. North America Veterinary Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Veterinary Biologics Revenue Market Share by Country (2016-2021)
Table 22. Europe Veterinary Biologics Sales by Country (2016-2021) & (K Units)
Table 23. Europe Veterinary Biologics Sales Market Share by Country (2016-2021)
Table 24. Europe Veterinary Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Veterinary Biologics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Veterinary Biologics Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Veterinary Biologics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Veterinary Biologics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Veterinary Biologics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Veterinary Biologics Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Veterinary Biologics Sales Market Share by Country (2016-2021)
Table 32. Latin America Veterinary Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Veterinary Biologics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Veterinary Biologics Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Veterinary Biologics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Veterinary Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Veterinary Biologics Revenue Market Share by Country (2016-2021)
Table 38. Global Veterinary Biologics Sales (K Units) by Type (2016-2021)
Table 39. Global Veterinary Biologics Sales Market Share by Type (2016-2021)
Table 40. Global Veterinary Biologics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Veterinary Biologics Revenue Share by Type (2016-2021)
Table 42. Global Veterinary Biologics Price (US$/Unit) by Type (2016-2021)
Table 43. Global Veterinary Biologics Sales (K Units) by Application (2016-2021)
Table 44. Global Veterinary Biologics Sales Market Share by Application (2016-2021)
Table 45. Global Veterinary Biologics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Veterinary Biologics Revenue Share by Application (2016-2021)
Table 47. Global Veterinary Biologics Price (US$/Unit) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Merck Veterinary Biologics Product
Table 52. Merck Recent Developments/Updates
Table 53. Zoetis Corporation Information
Table 54. Zoetis Description and Business Overview
Table 55. Zoetis Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Zoetis Veterinary Biologics Product
Table 57. Zoetis Recent Developments/Updates
Table 58. Boehringer Ingelheim Corporation Information
Table 59. Boehringer Ingelheim Description and Business Overview
Table 60. Boehringer Ingelheim Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Boehringer Ingelheim Veterinary Biologics Product
Table 62. Boehringer Ingelheim Recent Developments/Updates
Table 63. Ceva Corporation Information
Table 64. Ceva Description and Business Overview
Table 65. Ceva Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Ceva Veterinary Biologics Product
Table 67. Ceva Recent Developments/Updates
Table 68. CAHIC Corporation Information
Table 69. CAHIC Description and Business Overview
Table 70. CAHIC Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. CAHIC Veterinary Biologics Product
Table 72. CAHIC Recent Developments/Updates
Table 73. HVRI Corporation Information
Table 74. HVRI Description and Business Overview
Table 75. HVRI Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. HVRI Veterinary Biologics Product
Table 77. HVRI Recent Developments/Updates
Table 78. Ringpu Biology Corporation Information
Table 79. Ringpu Biology Description and Business Overview
Table 80. Ringpu Biology Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Ringpu Biology Veterinary Biologics Product
Table 82. Ringpu Biology Recent Developments/Updates
Table 83. Yebio Corporation Information
Table 84. Yebio Description and Business Overview
Table 85. Yebio Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Yebio Veterinary Biologics Product
Table 87. Yebio Recent Developments/Updates
Table 88. DHN Corporation Information
Table 89. DHN Description and Business Overview
Table 90. DHN Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. DHN Veterinary Biologics Product
Table 92. DHN Recent Developments/Updates
Table 93. WINSUN Corporation Information
Table 94. WINSUN Description and Business Overview
Table 95. WINSUN Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. WINSUN Veterinary Biologics Product
Table 97. WINSUN Recent Developments/Updates
Table 98. Elanco/Eli Lilly Corporation Information
Table 99. Elanco/Eli Lilly Description and Business Overview
Table 100. Elanco/Eli Lilly Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Elanco/Eli Lilly Veterinary Biologics Product
Table 102. Elanco/Eli Lilly Recent Developments/Updates
Table 103. Virbac Corporation Information
Table 104. Virbac Description and Business Overview
Table 105. Virbac Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Virbac Veterinary Biologics Product
Table 107. Virbac Recent Developments/Updates
Table 108. Jinyu Bio-Technology Corporation Information
Table 109. Jinyu Bio-Technology Description and Business Overview
Table 110. Jinyu Bio-Technology Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Jinyu Bio-Technology Veterinary Biologics Product
Table 112. Jinyu Bio-Technology Recent Developments/Updates
Table 113. ChengDu Tecbond Corporation Information
Table 114. ChengDu Tecbond Description and Business Overview
Table 115. ChengDu Tecbond Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. ChengDu Tecbond Veterinary Biologics Product
Table 117. ChengDu Tecbond Recent Developments/Updates
Table 118. CAVAC Corporation Information
Table 119. CAVAC Description and Business Overview
Table 120. CAVAC Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. CAVAC Veterinary Biologics Product
Table 122. CAVAC Recent Developments/Updates
Table 123. Kyoto Biken Corporation Information
Table 124. Kyoto Biken Description and Business Overview
Table 125. Kyoto Biken Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Kyoto Biken Veterinary Biologics Product
Table 127. Kyoto Biken Recent Developments/Updates
Table 128. FATRO Corporation Information
Table 129. FATRO Description and Business Overview
Table 130. FATRO Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. FATRO Veterinary Biologics Product
Table 132. FATRO Recent Developments/Updates
Table 133. Vaksindo Corporation Information
Table 134. Vaksindo Description and Business Overview
Table 135. Vaksindo Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Vaksindo Veterinary Biologics Product
Table 137. Vaksindo Recent Developments/Updates
Table 138. Bio-Labs Corporation Information
Table 139. Bio-Labs Description and Business Overview
Table 140. Bio-Labs Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Bio-Labs Veterinary Biologics Product
Table 142. Bio-Labs Recent Developments/Updates
Table 143. Avimex Animal Corporation Information
Table 144. Avimex Animal Description and Business Overview
Table 145. Avimex Animal Veterinary Biologics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Avimex Animal Veterinary Biologics Product
Table 147. Avimex Animal Recent Developments/Updates
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Veterinary Biologics Distributors List
Table 151. Veterinary Biologics Customers List
Table 152. Veterinary Biologics Market Trends
Table 153. Veterinary Biologics Growth Drivers
Table 154. Veterinary Biologics Market Restraints
Table 155. Global Veterinary Biologics Sales Forecast by Type (2022-2027) & (K Units)
Table 156. Global Veterinary Biologics Sales Market Share Forecast by Type (2022-2027)
Table 157. Global Veterinary Biologics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 158. Global Veterinary Biologics Revenue Market Share Forecast by Type (2022-2027)
Table 159. Global Veterinary Biologics Sales Forecast by Application (2022-2027) & (K Units)
Table 160. Global Veterinary Biologics Sales Market Share Forecast by Application (2022-2027)
Table 161. Global Veterinary Biologics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 162. Global Veterinary Biologics Revenue Market Share Forecast by Application (2022-2027)
Table 163. Global Veterinary Biologics Sales Forecast by Region (2022-2027) & (K Units)
Table 164. Global Veterinary Biologics Sales Market Share Forecast by Region (2022-2027)
Table 165. Global Veterinary Biologics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 166. Global Veterinary Biologics Revenue Market Share Forecast by Region (2022-2027)
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Veterinary Biologics
Figure 2. Global Veterinary Biologics Market Share by Type in 2020 & 2027
Figure 3. Vaccines Product Picture
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Global Veterinary Biologics Market Share by Application in 2020 & 2027
Figure 6. Llivestock
Figure 7. Equine
Figure 8. Other
Figure 9. Global Veterinary Biologics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Veterinary Biologics Market Size 2016-2027 (US$ Million)
Figure 11. Global Veterinary Biologics Sales 2016-2027 (K Units)
Figure 12. Global Veterinary Biologics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Veterinary Biologics Sales Share by Manufacturers in 2020
Figure 14. Global Veterinary Biologics Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Veterinary Biologics Players: Market Share by Revenue in 2020
Figure 16. Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Veterinary Biologics Sales Market Share by Region (2016-2021)
Figure 18. Global Veterinary Biologics Sales Market Share by Region in 2020
Figure 19. Global Veterinary Biologics Revenue Market Share by Region (2016-2021)
Figure 20. Global Veterinary Biologics Revenue Market Share by Region in 2020
Figure 21. U.S. Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Veterinary Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Veterinary Biologics by Type (2016-2021)
Figure 46. Sales Market Share of Veterinary Biologics by Application (2016-2021)
Figure 47. Sales Market Share of Veterinary Biologics by Application in 2020
Figure 48. Revenue Share of Veterinary Biologics by Application (2016-2021)
Figure 49. Revenue Share of Veterinary Biologics by Application in 2020
Figure 50. Manufacturing Cost Structure of Veterinary Biologics
Figure 51. Manufacturing Process Analysis of Veterinary Biologics
Figure 52. Veterinary Biologics Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs